Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 DiabetesThe New England journal of medicine, 2020-06, Vol.382 (26), p.2493-2503 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1916624 ;PMID: 32579810Full text available |
|
2 |
Material Type: Article
|
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with GoutThe New England journal of medicine, 2018-03, Vol.378 (13), p.1200-1210 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710895 ;PMID: 29527974Full text available |
|
3 |
Material Type: Article
|
Effects of Allopurinol on the Progression of Chronic Kidney DiseaseThe New England journal of medicine, 2020-06, Vol.382 (26), p.2504-2513 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1915833 ;PMID: 32579811Full text available |
|
4 |
Material Type: Article
|
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trialThe Lancet (British edition), 2022-10, Vol.400 (10359), p.1195-1205 [Peer Reviewed Journal]2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01657-9 ;PMID: 36216006Full text available |
|
5 |
Material Type: Article
|
Anti-inflammatory therapies for atherosclerosisNature reviews cardiology, 2015-04, Vol.12 (4), p.199-211 [Peer Reviewed Journal]COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2015 ;ISSN: 1759-5002 ;ISSN: 1759-5010 ;EISSN: 1759-5010 ;DOI: 10.1038/nrcardio.2015.5 ;PMID: 25666404Full text available |
|
6 |
Material Type: Article
|
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyCirculation (New York, N.Y.), 2015-05, Vol.131 (20), p.1763-1771 [Peer Reviewed Journal]2015 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.114.014536 ;PMID: 25986447Full text available |
|
7 |
Material Type: Article
|
Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort StudyCirculation (New York, N.Y.), 2018-09, Vol.138 (11), p.1116-1126 [Peer Reviewed Journal]2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.033992 ;PMID: 29899013Full text available |
|
8 |
Material Type: Article
|
Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational studyAnnals of the rheumatic diseases, 2013-06, Vol.72 (6), p.826-830 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2013 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2012-201676 ;PMID: 22679303 ;CODEN: ARDIAOFull text available |
|
9 |
Material Type: Article
|
Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled TrialJournal of the American Society of Nephrology, 2024-05, Vol.35 (5), p.594-606 [Peer Reviewed Journal]EISSN: 1533-3450 ;DOI: 10.1681/ASN.0000000000000326 ;PMID: 38564654Full text available |
|
10 |
Material Type: Article
|
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)Annals of the rheumatic diseases, 2017-05, Vol.76 (5), p.811-820 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-209213 ;PMID: 27821644 ;CODEN: ARDIAOFull text available |
|
11 |
Material Type: Article
|
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysisNephrology, dialysis, transplantation, 2014-02, Vol.29 (2), p.406-413 [Peer Reviewed Journal]ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gft378 ;PMID: 24042021Full text available |
|
12 |
Material Type: Article
|
Allopurinol does not improve cardiovascular outcomes in ischaemic heart diseaseEuropean heart journal, 2023-03, Vol.44 (12), p.1016-1017 [Peer Reviewed Journal]ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehad014 ;PMID: 36733214Full text available |
|
13 |
Material Type: Article
|
Serum urate outcomes of treat-to-target urate lowering treatment: results of a nationwide cohort study from 1997 to the COVID-19 pandemic using data from the Clinical Practice Research DatalinkAnnals of the rheumatic diseases, 2022-12, Vol.81 (12), p.1768-1769 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard-2022-222668 ;PMID: 35772867Full text available |
|
14 |
Material Type: Article
|
Uric Acid Reduction Rectifies Prehypertension in Obese AdolescentsHypertension (Dallas, Tex. 1979), 2012-11, Vol.60 (5), p.1148-1156 [Peer Reviewed Journal]2012 American Heart Association, Inc. ;2015 INIST-CNRS ;ISSN: 0194-911X ;EISSN: 1524-4563 ;DOI: 10.1161/HYPERTENSIONAHA.112.196980 ;PMID: 23006736 ;CODEN: HPRTDNFull text available |
|
15 |
Material Type: Article
|
A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With GoutArthritis & rheumatology (Hoboken, N.J.), 2016-08, Vol.68 (8), p.2027-2034 [Peer Reviewed Journal]2016 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology. ;2016, American College of Rheumatology ;ISSN: 2326-5191 ;EISSN: 2326-5205 ;DOI: 10.1002/art.39684 ;PMID: 26989892Full text available |
|
16 |
Material Type: Article
|
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular RiskClinical journal of the American Society of Nephrology, 2010-08, Vol.5 (8), p.1388-1393 [Peer Reviewed Journal]Copyright © 2010 by the American Society of Nephrology ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/CJN.01580210 ;PMID: 20538833Full text available |
|
17 |
Material Type: Article
|
Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3-year randomized parallel-controlled studyClinical endocrinology (Oxford), 2015-10, Vol.83 (4), p.475-482 [Peer Reviewed Journal]2014 John Wiley & Sons Ltd ;2014 John Wiley & Sons Ltd. ;Copyright © 2015 John Wiley & Sons Ltd ;ISSN: 0300-0664 ;EISSN: 1365-2265 ;DOI: 10.1111/cen.12673 ;PMID: 25400252Full text available |
|
18 |
Material Type: Article
|
Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic HyperuricemiaJournal of investigative medicine, 2015-12, Vol.63 (8), p.924-929 [Peer Reviewed Journal]2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 American Federation for Medical Research ;Copyright: 2015 (c) 2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 1081-5589 ;EISSN: 1708-8267 ;DOI: 10.1097/JIM.0000000000000242 ;PMID: 26571421Full text available |
|
19 |
Material Type: Article
|
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of AllopurinolPharmacological reviews, 2006-03, Vol.58 (1), p.87-114 [Peer Reviewed Journal]ISSN: 0031-6997 ;EISSN: 1521-0081 ;DOI: 10.1124/pr.58.1.6 ;PMID: 16507884Full text available |
|
20 |
Material Type: Article
|
Acquired reactive perforating dermatosis successfully treated with allopurinolAnais brasileiros de dermatología, 2024-01, Vol.99 (1), p.148-149 [Peer Reviewed Journal]2023 Sociedade Brasileira de Dermatologia ;2023 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. 2023 Sociedade Brasileira de Dermatologia ;This work is licensed under a Creative Commons Attribution 4.0 International License. ;ISSN: 0365-0596 ;ISSN: 1806-4841 ;EISSN: 1806-4841 ;DOI: 10.1016/j.abd.2022.06.009 ;PMID: 37722994Full text available |